PenderFund Capital Management »

Landos Biopharma shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Landos Biopharma (LABP) shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Landos Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Landos Biopharma held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Landos Biopharma by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $271k 9.3k 29.12

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Sangoma Technologies Corp Com New (SANG)
Novavax Note 5.000%12/1 Added (Principal)
Burford Cap Ord Shs (BUR)
PAR Technology Corporation (PAR)
Western Asset Emerging Mrkts Dbt Fnd (EMD)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Cable One Note 1.125% 3/1 (Principal)
Docebo (DCBO)
Aviat Networks Com New (AVNW)
Nuveen Insured Tax-Free Adv Munici (NEA)

View all positions for PenderFund Capital Management

Top funds holding Landos Biopharma

Perceptive Advisors
Deltec Asset Management
Virtu Financial
Geode Capital Management
Black Maple Capital Management
PenderFund Capital Management
UBS Group
Tower Research Capital
Acadian Asset Management
Royal Bank of Canada
Jpmorgan Chase & Co
Morgan Stanley
Wells Fargo & Company

View all funds holding Landos Biopharma